Decoding Inflammatory Bowel Disease: A Strategic Blueprint for Accelerating R&D with DNAnexus and Ovation

The right data coupled with the right tools and infrastructure addresses critical pain points in the drug discovery and development process, such as the need for precise biomarker identification, effective patient stratification, rapid translation of research findings, and maintained security and regulatory compliance.

In this solution brief, we discuss how the Ovation–DNAnexus partnership can empower IBD R&D programs by combining Ovation's valuable IBD patient datasets with the comprehensive functionality of the DNAnexus Precision Health Data Cloud.

To read the brief, please fill out the form, and feel free to contact us to further explore how this partnership can streamline your research processes, accelerate your path to discovery, and ultimately contribute to better therapeutic options for patients.